David Noskowitz, M.S.E. has been Vice President of Regulatory Affairs since October 2018. He brings over 30 years of regulatory affairs experience to Aldeyra. Most recently, Mr. Noskowitz was Executive Director of Regulatory Affairs at Mersana Therapeutics, which develops antibody-drug conjugates for oncology. Prior to that, he was head of regulatory affairs at Synta Pharmaceuticals. Previously, he held positions of increasing responsibility at Genzyme, Genetics Institute/Wyeth, Bristol-Myers Squibb and E.R. Squibb, and Sons. His experience spans multiple indications including oncology, immune/inflammatory conditions, cardiovascular, and rare diseases. Mr. Noskowitz received an M.Eng. degree in Chemical Engineering from the University of Virginia in Charlottesville, and earned both a B.S. in Environmental Engineering and a B.A. in Chemistry at the University of Rochester.